We are live on ! Find out more
IDIX

IDENIX PHARMACEUTICALS INC
IDIX

Delisted

IDIX was delisted on the 5th of August, 2014.

Back to rankings

97 hedge funds and large institutions have $357M invested in IDENIX PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 97 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more call options, than puts

Call options by funds: $4.01M | Put options by funds: $1.46M

Holders
97
Holders Change
+97
Holders Change %
–
% of All Funds
3.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
97
Increased
–
Reduced
–
Closed
–
Calls
$4.01M
Puts
$1.46M
Net Calls
+$2.55M
Net Calls Change
+$2.55M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$96.6M +$109M +26,767,000 New
BCPEM
2
Bain Capital Public Equity Management
Massachusetts
$45.7M +$51.8M +12,664,950 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$41.5M +$47M +11,492,452 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$21.2M +$24M +5,871,450 New
BFA
5
BlackRock Fund Advisors
California
$12.6M +$14.3M +3,502,163 New
BM
6
Bridger Management
New York
$11.8M +$13.3M +3,260,628 New
BIT
7
BlackRock Institutional Trust
California
$10.4M +$11.7M +2,870,020 New
CCM
8
Camber Capital Management
Massachusetts
$9.93M +$11.2M +2,750,000 New
State Street
9
State Street
Massachusetts
$9.71M +$11M +2,691,421 New
Fidelity Investments
10
Fidelity Investments
Massachusetts
$8.27M +$9.37M +2,290,683 New
Westfield Capital Management
11
Westfield Capital Management
Massachusetts
$6.68M +$7.57M +1,850,034 New
JHIU
12
Janus Henderson Investors US
Colorado
$5.88M +$6.66M +1,627,870 New
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$5.53M +$6.27M +1,532,107 New
Citadel Advisors
14
Citadel Advisors
Florida
$5.47M +$6.2M +1,514,978 New
VAM
15
Visium Asset Management
New York
$4.87M +$5.52M +1,350,000 New
Capital World Investors
16
Capital World Investors
California
$4.87M +$5.52M +1,349,979 New
Northern Trust
17
Northern Trust
Illinois
$4.7M +$5.33M +1,303,108 New
FAM
18
Fred Alger Management
New York
$4.53M +$5.13M +1,253,496 New
BB
19
BB Biotech
Switzerland
$4.51M +$5.11M +1,250,000 New
PHS
20
PFM Health Sciences
California
$4.21M +$4.77M +1,166,298 New
GAI
21
General American Investors
New York
$3.1M +$3.51M +858,979 New
RA
22
Royce & Associates
New York
$2.66M +$3.01M +736,000 New
Jennison Associates
23
Jennison Associates
New York
$2.66M +$3.01M +735,742 New
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$2.43M +$2.75M +672,491 New
ARC
25
Absolute Return Capital
Massachusetts
$2.24M +$2.54M +621,490 New
1
2 3 4

IDIX Hedge Fund Activity: Q2 2013 in Review

97 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q2 2013, worth a combined $357M.

Buyers outnumbered sellers: 97 funds opened new IDIX positions and 0 closed out — a net gain of 97 holders — while 0 added to existing stakes and 0 trimmed.

  • 97 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $357M of IDENIX PHARMACEUTICALS INC stock for Q2 2013.
  • 97 funds opened new IDENIX PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +97 holders.

Based on aggregated 13F filings for Q2 2013.